Christos Nikolaidis M.D.

Christos Nikolaidis MD, MSc, PhD is a Medical Director at GSK specializing in Oncology and Hematology with a focus on Multiple Myeloma since November 2024. Previously, Nikolaidis served as the Precision Oncology Lead for Roche, leading drug development and clinical trials for tumor agnostic and rare cancers from September 2020 to October 2024. Prior roles include consulting for integrated healthcare solutions in oncology at the EU and serving as a medical researcher at the University of Basel, establishing an international research consortium. Experience also includes a UICC Fellowship at The Ohio State University Wexner Medical Center, co-founding Pneumogenesis, and roles in public health and molecular diagnostics. Academic qualifications include a PhD in Epidemiology and an MD from Democritus University of Thrace, an MSc in Biotechnology from Imperial College London, and a Bachelor's degree in Biochemistry from the University of Kent. Currently, Nikolaidis is pursuing a degree in Clinical Pharmacology at the European Center of Pharmaceutical Medicine.